NAIMA as a solution for future GMO diagnostics challenges

被引:20
|
作者
Dobnik, David [1 ]
Morisset, Dany [1 ]
Gruden, Kristina [1 ]
机构
[1] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana 1000, Slovenia
关键词
Biochips; High-throughput screening; Multiplex; Genetically modified organisms; Detection; Quantification; Identification; POLYMERASE-CHAIN-REACTION; PCR; QUANTIFICATION; IDENTIFICATION;
D O I
10.1007/s00216-009-3197-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the field of genetically modified organism (GMO) diagnostics, real-time PCR has been the method of choice for target detection and quantification in most laboratories. Despite its numerous advantages, however, the lack of a true multiplexing option may render real-time PCR less practical in the face of future GMO detection challenges such as the multiplicity and increasing complexity of new transgenic events, as well as the repeated occurrence of unauthorized GMOs on the market. In this context, we recently reported the development of a novel multiplex quantitative DNA-based target amplification method, named NASBA implemented microarray analysis (NAIMA), which is suitable for sensitive, specific and quantitative detection of GMOs on a microarray. In this article, the performance of NAIMA is compared with that of real-time PCR, the focus being their performances in view of the upcoming challenge to detect/quantify an increasing number of possible GMOs at a sustainable cost and affordable staff effort. Finally, we present our conclusions concerning the applicability of NAIMA for future use in GMO diagnostics.
引用
收藏
页码:2229 / 2233
页数:5
相关论文
共 50 条
  • [1] NAIMA as a solution for future GMO diagnostics challenges
    David Dobnik
    Dany Morisset
    Kristina Gruden
    Analytical and Bioanalytical Chemistry, 2010, 396 : 2229 - 2233
  • [2] Application of NAIMA-MA for fast high throughput and quantitative GMO detection
    Morisset, Dany
    Dobnik, David
    Likar, Tina
    Gruden, Kristina
    JOURNAL OF BIOTECHNOLOGY, 2008, 136 : S247 - S248
  • [3] APS - Diagnostics and challenges for the future
    Pengo, V.
    Bison, E.
    Zoppellaro, G.
    Jose, S. Padayattil
    Denas, G.
    Hoxha, A.
    Ruffatti, A.
    Banzato, A.
    AUTOIMMUNITY REVIEWS, 2016, 15 (11) : 1031 - 1033
  • [4] Diagnostics in onchocerciasis: future challenges
    Boatin, BA
    Toe, L
    Alley, ES
    Dembele, N
    Weiss, N
    Dadzie, KY
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1998, 92 : S41 - S45
  • [5] Beam diagnostics challenges for future FELs
    Lumpkin, AH
    FREE-ELECTRON LASER CHALLENGES, 1997, 2988 : 70 - 77
  • [6] FERMI longitudinal diagnostics: results and future challenges
    Veronese, M.
    Ferrari, E.
    Allaria, E.
    Cinquegrana, P.
    Froelich, L.
    Giannessi, L.
    Penco, G.
    Predonzani, M.
    Rossi, F.
    Sigalotti, P.
    Ferianis, M.
    ADVANCES IN X-RAY FREE-ELECTRON LASERS INSTRUMENTATION III, 2015, 9512
  • [7] Current and future challenges in quality assurance in molecular diagnostics
    Ahmad-Nejad, Parviz
    Ashavaid, Tester
    Salinas, Aldo Vacaflores
    Huggett, Jim
    Harris, Kathryn
    Linder, Mark W.
    Baluchova, Katarina
    Steimer, Werner
    Payne, Deborah A.
    CLINICA CHIMICA ACTA, 2021, 519 : 239 - 246
  • [8] Molecular Diagnostics of Primary Immunodeficiencies Benefits and Future Challenges
    van der Burg, Mirjam
    van Zelm, Menno C.
    van Dongen, Jacques J. M.
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN V, 2009, 634 : 231 - 241
  • [9] GMO debate clouds future
    MacNeil, JS
    SCIENTIST, 2004, 18 (03): : 37 - 37
  • [10] Future challenges in rheumatology - is telemedicine the solution?
    de Thurah, Annette
    Marques, Andrea
    de Souza, Savia
    Crowson, Cynthia S.
    Myasoedova, Elena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14